Companies › INKT
MINK THERAPEUTICS INC (INKT)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001840229 · EDGAR filings · Updated 2026-06-23
MINK THERAPEUTICS INC (INKT) has reported institutional ownership of 2.5%, with 22 institutional managers holding positions valued at $1.32M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-06-23 — Current report (8-K) filed
- 2026-06-05 — Insider transaction reported (Form 4)
- 2026-06-02 — Insider transaction reported (Form 4)
- 2026-06-02 — Insider transaction reported (Form 4)
- 2026-06-02 — Insider transaction reported (Form 4)
- 2026-06-02 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, MINK THERAPEUTICS INC has 22 institutional holders and institutional ownership of 2.5%.
Insider activity
Insiders reported 26 transactions (0 buys, 6 sells) across 8 reporting insiders, with a net reported value of −$27.5K.
Data flags from SEC filings
Related companies
BioVie Inc (BIVI) · QUINCE THERAPEUTICS (QNCX) · AMERICAN SHARED HOSPITAL SVC (AMS) · NUTRIBAND INC (NTRB) · CDT EQUITY INC (CDT) · MILESTONE SCIENTIFIC INC (MLSS)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-23.